| Year |
Citation |
Score |
| 2023 |
Krill-Burger JM, Dempster JM, Borah AA, Paolella BR, Root DE, Golub TR, Boehm JS, Hahn WC, McFarland JM, Vazquez F, Tsherniak A. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal. Genome Biology. 24: 192. PMID 37612728 DOI: 10.1186/s13059-023-03020-w |
0.338 |
|
| 2022 |
Hoge ACH, Getz M, Zimmer A, Ko M, Raz L, Beroukhim R, Golub TR, Ha G, Ben-David U. Publisher Correction: DNA-based copy number analysis confirms genomic evolution of PDX models. Npj Precision Oncology. 6: 50. PMID 35821277 DOI: 10.1038/s41698-022-00293-5 |
0.681 |
|
| 2022 |
Hoge ACH, Getz M, Zimmer A, Ko M, Raz L, Beroukhim R, Golub TR, Ha G, David UB. DNA-based copy number analysis confirms genomic evolution of PDX models. Npj Precision Oncology. 6: 30. PMID 35484194 DOI: 10.1038/s41698-022-00268-6 |
0.506 |
|
| 2022 |
Bondeson DP, Paolella BR, Asfaw A, Rothberg MV, Skipper TA, Langan C, Mesa G, Gonzalez A, Surface LE, Ito K, Kazachkova M, Colgan WN, Warren A, Dempster JM, Krill-Burger JM, ... ... Golub TR, et al. Phosphate dysregulation via the XPR1-KIDINS220 protein complex is a therapeutic vulnerability in ovarian cancer. Nature Cancer. PMID 35437317 DOI: 10.1038/s43018-022-00360-7 |
0.332 |
|
| 2022 |
Pagès M, Rotem D, Gydush G, Reed S, Rhoades J, Ha G, Lo C, Fleharty M, Duran M, Jones R, Becker S, Haller M, Sinai CE, Goumnerova L, Golub TR, et al. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine. Neuro-Oncology. PMID 34984433 DOI: 10.1093/neuonc/noab299 |
0.473 |
|
| 2021 |
Malone CF, Dharia NV, Kugener G, Forman AB, Rothberg MV, Abdusamad M, Gonzalez A, Kuljanin M, Robichaud AL, Saur Conway A, Dempster JM, Paolella BR, Dumont N, Hovestadt V, Mancias JD, ... ... Golub TR, et al. Selective modulation of a pan-essential protein as a therapeutic strategy in cancer. Cancer Discovery. PMID 33883167 DOI: 10.1158/2159-8290.CD-20-1213 |
0.32 |
|
| 2021 |
Dharia NV, Kugener G, Guenther LM, Malone CF, Durbin AD, Hong AL, Howard TP, Bandopadhayay P, Wechsler CS, Fung I, Warren AC, Dempster JM, Krill-Burger JM, Paolella BR, Moh P, ... ... Golub TR, et al. A first-generation pediatric cancer dependency map. Nature Genetics. PMID 33753930 DOI: 10.1038/s41588-021-00819-w |
0.334 |
|
| 2021 |
Prensner JR, Enache OM, Luria V, Krug K, Clauser KR, Dempster JM, Karger A, Wang L, Stumbraite K, Wang VM, Botta G, Lyons NJ, Goodale A, Kalani Z, Fritchman B, ... ... Golub TR, et al. Noncanonical open reading frames encode functional proteins essential for cancer cell survival. Nature Biotechnology. PMID 33510483 DOI: 10.1038/s41587-020-00806-2 |
0.315 |
|
| 2021 |
Cohen-Sharir Y, McFarland JM, Abdusamad M, Marquis C, Bernhard SV, Kazachkova M, Tang H, Ippolito MR, Laue K, Zerbib J, Malaby HLH, Jones A, Stautmeister LM, Bockaj I, Wardenaar R, ... ... Golub TR, et al. Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition. Nature. PMID 33505028 DOI: 10.1038/s41586-020-03114-6 |
0.726 |
|
| 2020 |
Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, Humeidi R, Peck D, Wu X, Tang AA, Wang VM, Bender SA, Lemire E, Narayan R, Montgomery P, ... ... Golub TR, et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nature Cancer. 1: 235-248. PMID 32613204 DOI: 10.1038/s43018-019-0018-6 |
0.649 |
|
| 2020 |
Enache OM, Rendo V, Abdusamad M, Lam D, Davison D, Pal S, Currimjee N, Hess J, Pantel S, Nag A, Thorner AR, Doench JG, Vazquez F, Beroukhim R, Golub TR, et al. Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature Genetics. PMID 32587373 DOI: 10.1038/S41588-020-0663-9 |
0.664 |
|
| 2020 |
Enache OM, Rendo V, Abdusamad M, Lam D, Davison D, Pal S, Currimjee N, Hess J, Pantel S, Nag A, Thorner AR, Doench JG, Vazquez F, Beroukhim R, Golub TR, et al. Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nature Genetics. PMID 32424350 DOI: 10.1038/S41588-020-0623-4 |
0.725 |
|
| 2020 |
Corsello SM, Nagari RT, Spangler RD, Rossen J, Kocak M, Bryan JG, Humeidi R, Peck D, Wu X, Tang AA, Wang VM, Bender SA, Lemire E, Narayan R, Montgomery P, ... ... Golub TR, et al. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling Nature Cancer. 1: 235-248. DOI: 10.1038/s43018-019-0018-6 |
0.601 |
|
| 2019 |
Oberlick EM, Rees MG, Seashore-Ludlow B, Vazquez F, Nelson GM, Dharia NV, Weir BA, Tsherniak A, Ghandi M, Krill-Burger JM, Meyers RM, Wang X, Montgomery P, Root DE, Bieber JM, ... ... Golub TR, et al. Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors. Cell Reports. 28: 2331-2344.e8. PMID 31461650 DOI: 10.1016/J.Celrep.2019.07.021 |
0.353 |
|
| 2019 |
Ghandi M, Huang FW, Jané-Valbuena J, Kryukov GV, Lo CC, McDonald ER, Barretina J, Gelfand ET, Bielski CM, Li H, Hu K, Andreev-Drakhlin AY, Kim J, Hess JM, Haas BJ, ... ... Golub TR, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. PMID 31068700 DOI: 10.1038/S41586-019-1186-3 |
0.338 |
|
| 2019 |
Painter C, Jain E, Dunphy M, Anastasio E, McGillicuddy M, Stoddard R, Thomas B, Balch S, Anderka K, Larkin K, Lennon N, Chen Y, Zimmer A, Baker EO, Maiwald S, ... ... Golub T, et al. Abstract B085: High mutation burden and response to immune checkpoint inhibitors in angiosarcomas of the scalp and face Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B085 |
0.409 |
|
| 2019 |
Bender S, Zhu C, Wang L, Rothberg M, Dempster J, Paolella B, Kocak M, Laird M, Rossen J, Stumbraite K, Bryan J, Wang V, Doench J, Vazquez F, Tsherniak A, ... Golub T, et al. Abstract 2690: Massively parallel multiplexed methods to screen hundreds of barcoded cancer cell line models with small molecules or genetic perturbations using next-generation sequencing Cancer Research. 79: 2690-2690. DOI: 10.1158/1538-7445.Sabcs18-2690 |
0.405 |
|
| 2019 |
Boudreau A, Roth J, Rong J, Olsson N, Mader C, Byran J, Rossen J, Wang L, Larpenteur K, Goodale A, Trepicchio C, Bender S, Tsherniak A, Subramanian A, Kocak M, ... ... Golub T, et al. Abstract B121: An oncogene-linked prodrug strategy in lung cancer Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-B121 |
0.428 |
|
| 2018 |
Ben-David U, Beroukhim R, Golub TR. Genomic evolution of cancer models: perils and opportunities. Nature Reviews. Cancer. PMID 30578414 DOI: 10.1038/S41568-018-0095-3 |
0.716 |
|
| 2018 |
Durbin AD, Zimmerman MW, Dharia NV, Abraham BJ, Iniguez AB, Weichert-Leahey N, He S, Krill-Burger JM, Root DE, Vazquez F, Tsherniak A, Hahn WC, Golub TR, Young RA, Look AT, et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nature Genetics. PMID 30127528 DOI: 10.1038/S41588-018-0191-Z |
0.342 |
|
| 2018 |
Ben-David U, Siranosian B, Ha G, Tang H, Oren Y, Hinohara K, Strathdee CA, Dempster J, Lyons NJ, Burns R, Nag A, Kugener G, Cimini B, Tsvetkov P, Maruvka YE, ... ... Golub TR, et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature. PMID 30089904 DOI: 10.1038/S41586-018-0409-3 |
0.725 |
|
| 2018 |
Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, ... ... Golub TR, et al. Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature Medicine. PMID 29955182 DOI: 10.1038/S41591-018-0097-4 |
0.397 |
|
| 2018 |
Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, ... ... Golub TR, et al. Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature Medicine. PMID 29955181 DOI: 10.1038/S41591-018-0098-3 |
0.426 |
|
| 2018 |
Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, ... ... Golub TR, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nature Medicine. PMID 29713087 DOI: 10.1038/S41591-018-0016-8 |
0.483 |
|
| 2018 |
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, ... ... Golub TR, et al. Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq. Science (New York, N.Y.). 360: 331-335. PMID 29674595 DOI: 10.1126/Science.Aao4750 |
0.486 |
|
| 2018 |
Stover DG, Parsons HA, Ha G, Freeman SS, Barry WT, Guo H, Choudhury AD, Gydush G, Reed SC, Rhoades J, Rotem D, Hughes ME, Dillon DA, Partridge AH, Wagle N, ... ... Golub TR, et al. Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017760033. PMID 29298117 DOI: 10.1200/Jco.2017.76.0033 |
0.302 |
|
| 2018 |
Mullane SA, Painter C, Dunphy M, Anastasio E, Simoncelli T, Zarrelli K, Philippakis A, McKay RR, Choueiri TK, Golub T, Lander E, Wagle N, Van Allen EM. The Metastatic Prostate Cancer project (MPCproject): Translational genomics through direct patient engagement. Journal of Clinical Oncology. 36: 279-279. DOI: 10.1200/Jco.2018.36.6_Suppl.279 |
0.353 |
|
| 2018 |
Wagle N, Painter C, Van Allen EM, Bass AJ, Anastasio E, Dunphy M, McGillicuddy M, Stoddard R, Balch S, Thomas B, Tomson BN, Nguyen C, Jain E, Wankowicz S, Palma J, ... ... Golub T, et al. Count me in: A patient-driven research initiative to accelerate cancer research. Journal of Clinical Oncology. 36: e13501-e13501. DOI: 10.1200/Jco.2018.36.15_Suppl.E13501 |
0.344 |
|
| 2018 |
Golub T. Abstract IA05: Genomic approaches to drug discovery Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-Ia05 |
0.426 |
|
| 2018 |
Shee K, Hinds J, Yang W, Hampsch R, Patel K, Varn F, Cheng C, Jenkins N, Kettenbach A, Demidenko E, Owens P, Lanari C, Faber A, Golub T, Straussman R, et al. Abstract PD4-08: A microenvironment secretome screen reveals FGF2 as a mediator of resistance to anti-estrogens and PI3K/mTOR pathway inhibitors in ER+ breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd4-08 |
0.384 |
|
| 2018 |
Dunphy M, Jain E, Anastasio E, McGillicuddy M, Stoddard R, Thomas B, Balch S, Anderka K, Larkin K, Lennon N, Chen Y, Zimmer A, Baker EO, Maiwald S, Lapan JH, ... ... Golub T, et al. Abstract 5384: The Angiosarcoma Project: Generating the genomic landscape of an exceedingly rare cancer through a nationwide patient-driven initiative Cancer Research. 78: 5384-5384. DOI: 10.1158/1538-7445.Am2018-5384 |
0.399 |
|
| 2017 |
Chen L, Alexe G, Dharia NV, Ross L, Iniguez AB, Conway AS, Wang EJ, Veschi V, Lam N, Qi J, Gustafson WC, Nasholm N, Vazquez F, Weir BA, Cowley GS, ... ... Golub TR, et al. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. The Journal of Clinical Investigation. PMID 29202477 DOI: 10.1172/Jci90793 |
0.31 |
|
| 2017 |
Meyers RM, Bryan JG, McFarland JM, Weir BA, Sizemore AE, Xu H, Dharia NV, Montgomery PG, Cowley GS, Pantel S, Goodale A, Ali LD, Jiang G, Lubonja R, Harrington WF, ... ... Golub TR, et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nature Genetics. PMID 29083409 DOI: 10.1038/Ng.3984 |
0.308 |
|
| 2017 |
Ben-David U, Ha G, Tseng YY, Greenwald NF, Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R, Golub TR. Patient-derived xenografts undergo mouse-specific tumor evolution. Nature Genetics. PMID 28991255 DOI: 10.1038/Ng.3967 |
0.727 |
|
| 2017 |
Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, Gill S, Harrington WF, Pantel S, Krill-Burger JM, Meyers RM, Ali L, Goodale A, Lee Y, Jiang G, ... ... Golub TR, et al. Defining a Cancer Dependency Map. Cell. 170: 564-576.e16. PMID 28753430 DOI: 10.1016/J.Cell.2017.06.010 |
0.359 |
|
| 2017 |
Mullane SA, Painter C, Dunphy M, Anastasio E, Simoncelli T, Zarrelli K, Philippakis A, McKay RR, Choueiri TK, Golub T, Lander E, Wagle N, Van Allen EM. The Prostate Cancer Project (PC Project): Translational genomics through direct patient engagement. Journal of Clinical Oncology. 35: 199-199. DOI: 10.1200/Jco.2017.35.6_Suppl.199 |
0.337 |
|
| 2017 |
Painter C, Dunphy M, Anastasio E, McGillicuddy M, Anderka K, Larkin K, Lennon N, Chen Y, Lander E, Golub T, Wagle N. The Angiosarcoma Project: Generating the genomic landscape of a rare cancer through a direct-to-patient initiative. Journal of Clinical Oncology. 35: 1519-1519. DOI: 10.1200/Jco.2017.35.15_Suppl.1519 |
0.317 |
|
| 2017 |
Wagle N, Painter C, Anastasio E, Dunphy M, McGillicuddy M, Kim D, Jain E, Buendia-Buendia J, Cohen O, Knelson E, Holloway J, Johnson S, Larkin K, Adalsteinsson V, Ha G, ... ... Golub T, et al. The Metastatic Breast Cancer (MBC) project: Accelerating translational research through direct patient engagement. Journal of Clinical Oncology. 35: 1076-1076. DOI: 10.1200/Jco.2017.35.15_Suppl.1076 |
0.326 |
|
| 2017 |
Tsherniak A, Vazquez F, Weir B, Montgomery P, Cowley G, Gill S, Kryukov G, Pantel S, Harrington W, Burger M, Meyers R, Ali L, Goodale A, Lee Y, Garraway L, ... ... Golub T, et al. Abstract PR02: Towards a Cancer Dependency Map Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-Pr02 |
0.45 |
|
| 2017 |
Tseng Y(, Hong A, Gill S, Keskula P, Raghavan S, Cheah J, Tsherniak A, Vazquez F, Alkhairy S, Peng A, Sayeed A, Deasy R, Ronning P, Kantoff P, Garraway L, ... ... Golub T, et al. Abstract A02: Expanding tumor chemical-genetic interaction map using next-generation cancer models Molecular Cancer Therapeutics. 16. DOI: 10.1158/1538-8514.Synthleth-A02 |
0.464 |
|
| 2017 |
Shee K, Hinds J, Hampsch R, Golub T, Straussman R, Miller T. Abstract P3-03-01: A novel high-throughput secreted factor screen and bioinformatics pipeline identifies microenvironment-derived FGF2 as a mechanism of resistance to anti-estrogens, PI3K, and mTOR inhibitors in ER+ breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P3-03-01 |
0.324 |
|
| 2017 |
Painter C, Anastasio E, Krevalin M, Kim D, Larken K, Lennon N, Frank E, Winer E, Lander E, Golub T. Abstract P1-05-13: The metastatic breast cancer project: Translational genomics through direct patient engagement Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-05-13 |
0.361 |
|
| 2017 |
Tseng Y, Hong A, Keskula P, Gill S, Cheah J, Kryukov G, Tsherniak A, Vazquez F, Cowley G, Alkhairy S, Oh C, Peng A, Deasy R, Sayeed A, Ronning P, ... ... Golub T, et al. Abstract 1953: Accelerating prediction of pediatric and rare cancer vulnerabilities using next-generation cancer models Cancer Research. 77: 1953-1953. DOI: 10.1158/1538-7445.Am2017-1953 |
0.345 |
|
| 2016 |
Van Voorhis WC, Adams JH, Adelfio R, Ahyong V, Akabas MH, Alano P, Alday A, Alemán Resto Y, Alsibaee A, Alzualde A, Andrews KT, Avery SV, Avery VM, Ayong L, Baker M, ... ... Golub T, et al. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. Plos Pathogens. 12: e1005763. PMID 27467575 DOI: 10.1371/Journal.Ppat.1005763 |
0.315 |
|
| 2016 |
Ben-David U, Ha G, Khadka P, Jin X, Wong B, Franke L, Golub TR. The landscape of chromosomal aberrations in breast cancer mouse models reveals driver-specific routes to tumorigenesis. Nature Communications. 7: 12160. PMID 27374210 DOI: 10.1038/Ncomms12160 |
0.667 |
|
| 2016 |
Aguirre AJ, Meyers RM, Weir BA, Vazquez F, Zhang CZ, Ben-David U, Cook A, Ha G, Harrington WF, Doshi MB, Kost-Alimova M, Gill S, Xu H, Ali LD, Jiang G, ... ... Golub TR, et al. Genomic copy number dictates a gene-independent cell response to CRISPR-Cas9 targeting. Cancer Discovery. PMID 27260156 DOI: 10.1158/2159-8290.Cd-16-0154 |
0.685 |
|
| 2016 |
Kim E, Ilic N, Shrestha Y, Zou L, Kamburov A, Zhu C, Yang X, Lubonja R, Tran N, Nguyen C, Lawrence MS, Piccioni F, Bagul M, Doench JG, Chouinard CR, ... ... Golub TR, et al. Systematic functional interrogation of rare cancer variants identifies oncogenic alleles. Cancer Discovery. PMID 27147599 DOI: 10.1158/2159-8290.Cd-16-0160 |
0.338 |
|
| 2016 |
Kryukov GV, Wilson FH, Ruth JR, Paulk J, Tsherniak A, Marlow SE, Vazquez F, Weir BA, Fitzgerald ME, Tanaka M, Bielski CM, Scott JM, Dennis C, Cowley GS, Boehm JS, ... ... Golub TR, et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science (New York, N.Y.). PMID 26912360 DOI: 10.1126/Science.Aad5214 |
0.392 |
|
| 2016 |
Wagle N, Painter C, Krevalin M, Oh C, Anderka K, Larkin K, Lennon N, Dillon D, Frank E, Winer EP, Lander E, Golub T. The Metastatic Breast Cancer Project: A national direct-to-patient initiative to accelerate genomics research. Journal of Clinical Oncology. 34: LBA1519-LBA1519. DOI: 10.1200/Jco.2016.34.18_Suppl.Lba1519 |
0.377 |
|
| 2016 |
Wagle N, Painter C, Ilzarbe M, Allen EV, Frank E, Oh C, Krevalin M, Lloyd M, Anderka K, Kryukov G, Boehm J, Winer E, Lander E, Golub T. Abstract OT2-05-03: The metastatic breast cancer project: A national direct-to-patient research initiative to accelerate genomics research Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Ot2-05-03 |
0.4 |
|
| 2016 |
Tseng Y, Hong A, Keskula P, Gill S, Cheah J, Kryukov G, Tsherniak A, Vazquez F, Cowley G, Oh C, Peng A, Sayeed A, Deasy R, Ronning P, Kantoff P, ... ... Golub T, et al. Abstract 4367: Accelerating prediction of tumor vulnerabilities using next-generation cancer models Cancer Research. 76: 4367-4367. DOI: 10.1158/1538-7445.Am2016-4367 |
0.459 |
|
| 2015 |
Bergthold G, Bandopadhayay P, Hoshida Y, Ramkissoon S, Ramkissoon L, Rich B, Maire CL, Paolella BR, Schumacher SE, Tabak B, Ferrer-Luna R, Ozek M, Sav A, Santagata S, Wen PY, ... ... Golub T, et al. Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype. Neuro-Oncology. PMID 25825052 DOI: 10.1093/Neuonc/Nov045 |
0.536 |
|
| 2015 |
Berger A, Brooks A, Wu X, Hogstrom L, Tirosh I, Piccioni F, Bagul M, Zhu C, Shretha Y, Root D, Tamayo P, Sakai R, Wong B, Subramanian A, Golub T, et al. Abstract PR12: High-throughput gene expression profiling as a generalizable assay for determination of mutation impact on gene function Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr12 |
0.396 |
|
| 2015 |
Berger A, Brooks A, Wu X, Hogstrom L, Tirosh I, Piccioni F, Bagul M, Zhu C, Shretha Y, Root D, Tamayo P, Sakai R, Wong B, Subramanian A, Golub T, et al. Abstract PR04: High-throughput gene expression profiling as a generalizable assay for determination of mutation impact on gene function Cancer Research. 75. DOI: 10.1158/1538-7445.Compsysbio-Pr04 |
0.392 |
|
| 2015 |
Berger A, Kim E, Brooks A, Shrestha Y, Tseng Y, Wu X, Ilic N, Zou L, Kamburov A, Yang X, Zhu C, Keskula P, Seepo S, Hong A, Doench J, ... ... Golub T, et al. Abstract 957: Towards precision functional genomics via next-generation functional mapping of cancer variants Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2015-957 |
0.343 |
|
| 2015 |
Filbin MG, Tirosh I, Escalante LE, Venteicher AS, Hebert C, Goumnerova L, Ligon KL, Golub T, Regev A, Suva ML. PTPS-06SINGLE-CELL TRANSCRIPTOME ANALYSIS IN PEDIATRIC HIGH-GRADE GLIOMA Neuro-Oncology. 17: v180.2-v180. DOI: 10.1093/Neuonc/Nov228.06 |
0.39 |
|
| 2014 |
Cowley GS, Weir BA, Vazquez F, Tamayo P, Scott JA, Rusin S, East-Seletsky A, Ali LD, Gerath WF, Pantel SE, Lizotte PH, Jiang G, Hsiao J, Tsherniak A, Dwinell E, ... ... Golub TR, et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Scientific Data. 1: 140035. PMID 25984343 DOI: 10.1038/Sdata.2014.35 |
0.314 |
|
| 2014 |
Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, Helman E, Taylor-Weiner A, McKenna A, DeLuca DS, Lawrence MS, ... ... Golub TR, et al. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proceedings of the National Academy of Sciences of the United States of America. 111: E5564-73. PMID 25512523 DOI: 10.1073/Pnas.1419260111 |
0.311 |
|
| 2014 |
Deangelo DJ, Neuberg D, Amrein PC, Berchuck J, Wadleigh M, Sirulnik LA, Galinsky I, Golub T, Stegmaier K, Stone RM. A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia. Leukemia Research. 38: 430-4. PMID 24522247 DOI: 10.1016/J.Leukres.2013.10.026 |
0.304 |
|
| 2014 |
Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 505: 495-501. PMID 24390350 DOI: 10.1038/Nature12912 |
0.312 |
|
| 2014 |
Golub TR. The Somatic Cancer Genome Blood. 124: SCI-4-SCI-4. DOI: 10.1182/BLOOD.V124.21.SCI-4.SCI-4 |
0.344 |
|
| 2014 |
Kiezun A, Perry J, Tonzi P, Allen EV, Carter SL, Baca S, Bhatt A, Lawrence M, Walensky L, Wagle N, Mora J, deTorres C, Lavarino C, Velasco-Hidalgo L, Cardenas-Cardos R, ... ... Golub T, et al. Abstract A41: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A41 |
0.434 |
|
| 2014 |
Crompton B, Stewart C, Taylor-Weiner A, Alexa G, Kurek K, Calicchio M, Kiezun A, Carter S, Shukla S, Mehta S, Thorner A, Torres Cd, Lavarino C, Sunol M, McKenna A, ... ... Golub T, et al. Abstract 999: The genomic landscape of pediatric Ewing sarcoma Cancer Research. 74: 999-999. DOI: 10.1158/1538-7445.Am2014-999 |
0.449 |
|
| 2013 |
Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D, Doench JG, Bogusz AM, Habermann TM, Dogan A, Witzig TE, Kutok JL, Rodig SJ, Golub T, Shipp MA. SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas. Cancer Cell. 23: 826-38. PMID 23764004 DOI: 10.1016/J.Ccr.2013.05.002 |
0.322 |
|
| 2013 |
Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, ... ... Golub TR, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genetics. 45: 478-86. PMID 23525077 DOI: 10.1038/Ng.2591 |
0.495 |
|
| 2013 |
Keats J, Yellapantula V, Liang W, Kurdoglu A, Baker A, Levy J, Golub T, Craig D, Carpten J. Abstract 806: RNA sequencing based prognostic indexes show a high degree of correlation with historic array based gene expression measurements in multiple myeloma. Cancer Research. 73: 806-806. DOI: 10.1158/1538-7445.Am2013-806 |
0.411 |
|
| 2013 |
Li W, Han J, Widlund H, Correll M, Wang Y, Quackenbush J, Mihm M, Canales AL, Golub T, Hoshida Y, Hunter D, Murphy G, Kupper T, Qureshi A. Abstract 1347: CXCR4 pathway associated with family history of melanoma. Cancer Research. 73: 1347-1347. DOI: 10.1158/1538-7445.Am2013-1347 |
0.339 |
|
| 2012 |
Monti S, Chapuy B, Takeyama K, Rodig SJ, Hao Y, Yeda KT, Inguilizian H, Mermel C, Currie T, Dogan A, Kutok JL, Beroukhim R, Neuberg D, Habermann TM, Getz G, ... ... Golub TR, et al. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell. 22: 359-72. PMID 22975378 DOI: 10.1016/J.Ccr.2012.07.014 |
0.506 |
|
| 2012 |
Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, Biegel JA, Getz G, Roberts CW. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. The Journal of Clinical Investigation. 122: 2983-8. PMID 22797305 DOI: 10.1172/JCI64400 |
0.301 |
|
| 2012 |
Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, Cortes ML, Fernandez-Lopez JC, Peng S, Ardlie KG, Auclair D, ... ... Golub TR, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 486: 405-9. PMID 22722202 DOI: 10.1038/Nature11154 |
0.523 |
|
| 2012 |
Wei G, Margolin AA, Haery L, Brown E, Cucolo L, Julian B, Shehata S, Kung AL, Beroukhim R, Golub TR. Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency. Cancer Cell. 21: 547-62. PMID 22516262 DOI: 10.1016/J.Ccr.2012.02.028 |
0.535 |
|
| 2012 |
Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, ... ... Golub TR, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 483: 603-7. PMID 22460905 DOI: 10.1038/Nature11003 |
0.362 |
|
| 2012 |
Shrestha Y, Schafer EJ, Boehm JS, Thomas SR, He F, Du J, Wang S, Barretina J, Weir BA, Zhao JJ, Polyak K, Golub TR, Beroukhim R, Hahn WC. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene. 31: 3397-408. PMID 22105362 DOI: 10.1038/Onc.2011.515 |
0.504 |
|
| 2012 |
Chapuy B, Monti S, Takeyama K, Rodig SJ, Hao Y, Yeda KT, Inguilizian H, Mermel C, Currie T, Dogan A, Kutok J, Beroukhim R, Neuberg DS, Habermann TM, Getz G, ... ... Golub TR, et al. A Structural Basis for p53-Deficiency, Deregulated Cell Cycle and Unfavorable Outcome in Diffuse Large B-Cell Lymphoma Blood. 120: 1534-1534. DOI: 10.1182/Blood.V120.21.1534.1534 |
0.51 |
|
| 2012 |
Hodis E, Watson I, Theurillat J, Zou L, Place C, Nickerson E, Auclair D, Cibulskis K, Sivachenko A, Kryukov G, Stransky N, Ramos AH, Voet D, Lawrence MS, Stojanov P, ... ... Golub T, et al. Abstract 5056: A glimpse into the somatic mutation landscape of melanoma through exome sequencing of 121 tumor-normal pairs Cancer Research. 72: 5056-5056. DOI: 10.1158/1538-7445.Am2012-5056 |
0.408 |
|
| 2012 |
Shoni M, Du J, Yang J, Ng S, Muto MG, Welch W, Crum C, Berkowitz R, Golub T, Ng S. Abstract 1271: Aberrant activation of Spleen Tyrosine Kinase in ovarian cancer identified through a global phosphorylation profiling of protein tyrosine kinases Cancer Research. 72: 1271-1271. DOI: 10.1158/1538-7445.Am2012-1271 |
0.37 |
|
| 2011 |
Rice KL, Lin X, Wolniak K, Ebert BL, Berkofsky-Fessler W, Buzzai M, Sun Y, Xi C, Elkin P, Levine R, Golub T, Gilliland DG, Crispino JD, Licht JD, Zhang W. Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms. Blood Cancer Journal. 1: e40. PMID 22829077 DOI: 10.1038/Bcj.2011.39 |
0.338 |
|
| 2011 |
Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 475: 231-4. PMID 21753854 DOI: 10.1038/Nature10167 |
0.306 |
|
| 2011 |
Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, Anderson KC, Ardlie KG, Auclair D, Baker A, Bergsagel PL, ... ... Golub TR, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 471: 467-72. PMID 21430775 DOI: 10.1038/Nature09837 |
0.303 |
|
| 2011 |
Kryukov GV, Berger MF, Stransky N, Barretina J, Onofrio R, Caponigro G, Sougnez C, Monahan J, Shefler E, Venkhatesan K, Cibulskis K, Morais P, Sivachenko A, Meltzer J, Lawrence M, ... ... Golub T, et al. Abstract 923: Separating the wheat from the chaff: A first look at the Cancer Cell Lines Encyclopedia sequencing data Cancer Research. 71: 923-923. DOI: 10.1158/1538-7445.Am2011-923 |
0.461 |
|
| 2011 |
Barretina J, Stransky N, Caponigro G, Kim S, Margolin A, Venkhatesan K, Kryukov G, Berger M, Monahan J, Morais P, Meltzer J, Mahan S, Sonkin D, Raman P, Jones M, ... ... Golub T, et al. Abstract 5455: Integrative analysis of the Cancer Cell Line Encyclopedia reveals genetic and transcriptional predictors of compound sensitivity Cancer Research. 71: 5455-5455. DOI: 10.1158/1538-7445.Am2011-5455 |
0.469 |
|
| 2011 |
Stransky N, Egloff AM, Tward A, Auclair D, Cibulskis K, Lawrence M, Sivachenko A, Berger M, Seethala R, Sougnez C, Cortes M, Winckler W, Gabriel S, Getz G, Golub T, et al. Abstract 3931: Whole genome and whole exome sequencing of head and neck cancer Cancer Research. 71: 3931-3931. DOI: 10.1158/1538-7445.Am2011-3931 |
0.447 |
|
| 2010 |
Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, Scott KL, Kwong LN, Xiao Y, Cordon-Cardo C, Granter SR, Ramaswamy S, Golub T, Duncan LM, Wagner SN, et al. Integrative genome comparison of primary and metastatic melanomas. Plos One. 5: e10770. PMID 20520718 DOI: 10.1371/Journal.Pone.0010770 |
0.407 |
|
| 2010 |
Oliver TG, Mercer KL, Sayles LC, Burke JR, Mendus D, Lovejoy KS, Cheng MH, Subramanian A, Mu D, Powers S, Crowley D, Bronson RT, Whittaker CA, Bhutkar A, Lippard SJ, ... Golub T, et al. Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes & Development. 24: 837-52. PMID 20395368 DOI: 10.1101/Gad.1897010 |
0.408 |
|
| 2010 |
Golub T. Counterpoint: Data first. Nature. 464: 679. PMID 20360719 DOI: 10.1038/464679A |
0.378 |
|
| 2010 |
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, ... ... Golub TR, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 463: 899-905. PMID 20164920 DOI: 10.1038/Nature08822 |
0.545 |
|
| 2010 |
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 17: 98-110. PMID 20129251 DOI: 10.1016/J.Ccr.2009.12.020 |
0.307 |
|
| 2010 |
Baker AS, Shanmugam V, Salhia B, Keats J, Chapman M, Moore A, Chewining K, Ahmann G, Mfuko B, Levy J, Perkins L, Auclair D, Golub T, Bergsagel PL, Fonseca R, et al. Abstract 4822: Analysis of somatic copy number alterations associated with poor prognosis and progression of multiple myeloma in African Americans Cancer Research. 70: 4822-4822. DOI: 10.1158/1538-7445.Am10-4822 |
0.368 |
|
| 2010 |
Barretina J, Caponigro G, Kim S, Stransky N, Venkhatesan K, Reddy V, Berger M, Morrissey M, Morais P, Meltzer J, Thibault J, Mahan S, Sonkin D, Che J, Raman P, ... ... Golub T, et al. Abstract 2620: The Cancer Cell Line Encyclopedia project: From integrative cancer genomics to personalized cancer therapy Cancer Research. 70: 2620-2620. DOI: 10.1158/1538-7445.Am10-2620 |
0.492 |
|
| 2010 |
Stransky N, Venkhatesan K, Morrissey M, Barretina J, Raman P, Getz G, Berger M, Johannessen C, Callahan A, Morais P, Mahan S, Gupta S, Onofrio R, Sougnez C, Winckler W, ... ... Golub T, et al. Abstract 105: Integrative analysis of genomic and pharmacologic data from the Cancer Cell Line Encyclopedia Cancer Research. 70: 105-105. DOI: 10.1158/1538-7445.Am10-105 |
0.489 |
|
| 2010 |
Stransky N, Venkatesan K, Barretina J, Caponigro G, Margolin A, Morrissey M, Raman P, Getz G, Berger M, Johannessen C, Callahan A, Morais P, Mahan S, Gupta S, Onofrio R, ... ... Golub T, et al. Abstract PR4: Integrative analysis of genomic and pharmacologic data from the Cancer Cell Line Encyclopedia Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-Pr4 |
0.462 |
|
| 2010 |
Baker AS, Chapman M, Braggio E, Keats J, Mfuko B, Ahmann G, Sanmugam V, Salhia B, Moore A, Chewning K, Levy J, Perkins L, Auclair D, Golub T, Bergsagel PL, et al. Abstract B64: Analysis of somatic copy number alterations among African American patients with multiple myeloma using array CGH Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B64 |
0.39 |
|
| 2009 |
Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA, Lockhart VL, Shah SP, Tanwar PS, Mermel CH, Beroukhim R, Azam M, ... ... Golub TR, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nature Genetics. 41: 843-8. PMID 19483683 DOI: 10.1038/Ng.392 |
0.459 |
|
| 2009 |
Du J, Bernasconi P, Clauser KR, Mani DR, Finn SP, Beroukhim R, Burns M, Julian B, Peng XP, Hieronymus H, Maglathlin RL, Lewis TA, Liau LM, Nghiemphu P, Mellinghoff IK, ... ... Golub TR, et al. Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature Biotechnology. 27: 77-83. PMID 19098899 DOI: 10.1038/Nbt.1513 |
0.453 |
|
| 2008 |
Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, Hinkle G, Boehm JS, Beroukhim R, Weir BA, Mermel C, Barbie DA, Awad T, Zhou X, Nguyen T, ... ... Golub TR, et al. Highly parallel identification of essential genes in cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 20380-5. PMID 19091943 DOI: 10.1073/Pnas.0810485105 |
0.592 |
|
| 2008 |
Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, ... ... Golub T, et al. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nature Medicine. 14: 822-7. PMID 18641660 DOI: 10.1038/Nm.1790 |
0.311 |
|
| 2008 |
Huang G, Eisenberg R, Yan M, Monti S, Lawrence E, Fu P, Walbroehl J, Löwenberg E, Golub T, Merchan J, Tenen DG, Markowitz SD, Halmos B. 15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer. Cancer Research. 68: 5040-8. PMID 18593902 DOI: 10.1158/0008-5472.Can-07-6575 |
0.406 |
|
| 2008 |
Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, Laine E, Greulich H, Tseng H, Gates C, Hodi FS, Dranoff G, Sellers WR, Thomas RK, Meyerson M, ... Golub TR, et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Research. 68: 664-73. PMID 18245465 DOI: 10.1158/0008-5472.Can-07-2615 |
0.544 |
|
| 2008 |
Takeyama K, Monti S, Manis JP, Dal Cin P, Getz G, Beroukhim R, Dutt S, Aster JC, Alt FW, Golub TR, Shipp MA. Integrative analysis reveals 53BP1 copy loss and decreased expression in a subset of human diffuse large B-cell lymphomas. Oncogene. 27: 318-22. PMID 17637749 DOI: 10.1038/Sj.Onc.1210650 |
0.489 |
|
| 2008 |
Chapman MA, Brunet J, Baker A, Keats J, Ahmann G, Schinzel AC, Moore A, Shanmugam V, Perkins LM, Auclair D, Hahn WC, Bergsagel PL, Fonseca R, Carpten J, Trent J, ... Golub TR, et al. Interim Analyses of the MMRC Reference Collection Identifies Recurrent Genomic-Level Events in Multiple Myeloma and Demonstrates That CDKN2C/p18 Deletion Is the Pre-Eminent Copy Number Alteration in Poor Prognosis Disease Blood. 112: 497-497. DOI: 10.1182/Blood.V112.11.497.497 |
0.328 |
|
| 2007 |
Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, ... ... Golub TA, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America. 104: 20007-12. PMID 18077431 DOI: 10.1073/Pnas.0710052104 |
0.523 |
|
| 2007 |
Vivanco I, Palaskas N, Tran C, Finn SP, Getz G, Kennedy NJ, Jiao J, Rose J, Xie W, Loda M, Golub T, Mellinghoff IK, Davis RJ, Wu H, Sawyers CL. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell. 11: 555-69. PMID 17560336 DOI: 10.1016/J.Ccr.2007.04.021 |
0.402 |
|
| 2007 |
Stegmaier K, Wong JS, Ross KN, Chow KT, Peck D, Wright RD, Lessnick SL, Kung AL, Golub TR. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. Plos Medicine. 4: e122. PMID 17425403 DOI: 10.1371/Journal.Pmed.0040122 |
0.611 |
|
| 2007 |
Trent J, Carpten J, Reich M, Liefeld T, Keats J, Mousses S, Hahn W, Trudel S, Siegel D, Rajkumar SV, Alsina M, Richardson P, Anderson K, Auclair D, Perkins LM, ... ... Golub TR, et al. The Multiple Myeloma Research Consortium Genomics Initiative. Blood. 110: 2498-2498. DOI: 10.1182/Blood.V110.11.2498.2498 |
0.313 |
|
| 2007 |
Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, Golub TR, Lessnick SL. Expression Profiling of EWS/FLI Identifies NKX2.2 as a Critical Target Gene in Ewing's Sarcoma (DOI:10.1016/j.ccr.2006.04.004) Cancer Cell. 11: 97. DOI: 10.1016/J.Ccr.2006.12.009 |
0.635 |
|
| 2006 |
Kobayashi S, Shimamura T, Monti S, Steidl U, Hetherington CJ, Lowell AM, Golub T, Meyerson M, Tenen DG, Shapiro GI, Halmos B. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling. Cancer Research. 66: 11389-98. PMID 17145885 DOI: 10.1158/0008-5472.Can-06-2318 |
0.334 |
|
| 2006 |
Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, Golub TR, Lessnick SL. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell. 9: 405-16. PMID 16697960 DOI: 10.1016/J.Ccr.2006.04.004 |
0.729 |
|
| 2006 |
Febbo PG, Thorner A, Rubin MA, Loda M, Kantoff PW, Oh WK, Golub T, George D. Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 152-8. PMID 16397037 DOI: 10.1158/1078-0432.Ccr-05-1652 |
0.32 |
|
| 2005 |
Shepard JL, Amatruda JF, Stern HM, Subramanian A, Finkelstein D, Ziai J, Finley KR, Pfaff KL, Hersey C, Zhou Y, Barut B, Freedman M, Lee C, Spitsbergen J, Neuberg D, ... ... Golub TR, et al. A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proceedings of the National Academy of Sciences of the United States of America. 102: 13194-9. PMID 16150706 DOI: 10.1073/Pnas.0506583102 |
0.363 |
|
| 2005 |
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 436: 117-22. PMID 16001072 DOI: 10.1038/Nature03664 |
0.58 |
|
| 2005 |
Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, Ladd-Acosta C, Mesirov J, Golub TR, Jacks T. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nature Genetics. 37: 48-55. PMID 15608639 DOI: 10.1038/Ng1490 |
0.33 |
|
| 2004 |
Gu T, Tam WF, Chen J, Lee BH, Wang AZ, Cooper MR, Monti S, Golub T, Gilliland GD. Oncogenic Tyrosine Kinases Regulate Proliferative and Survival Signals through Activation of Id1. Blood. 104: 417-417. DOI: 10.1182/Blood.V104.11.417.417 |
0.347 |
|
| 2002 |
Lessnick SL, Dacwag CS, Golub TR. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell. 1: 393-401. PMID 12086853 DOI: 10.1016/S1535-6108(02)00056-9 |
0.611 |
|
| 1995 |
Sato Y, Suto Y, Pietenpol J, Golub T, Gilliland D, Davis E, Le Beau M, Roberts J, Vogelstein B, Rowley J. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies Blood. 86: 1525-1533. DOI: 10.1182/Blood.V86.4.1525.Bloodjournal8641525 |
0.314 |
|
| Show low-probability matches. |